Skip to content

DRDGOLD

US · DRD #2744 by market cap Listed 1970
23.70 -0.71 -2.91%
Live - 5344 symbols - heartbeat 184s ago · 2026-10-08 07:37
Pre-market 23.50 -0.84%
After-hours 23.95 +1.05%
Market cap
2.06B
P/B
2.68
EPS
2.95
Reader sentiment Are you bullish or bearish on DRD?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
22.71 fair value ≈ 33.91 45.10
  • Implied fair-value range of 22.71-45.10, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -30.1% below the average-multiple fair value of 33.91.

Valuation each multiple against its own 5-year range

P/B ratio 2.75 In line with history 60th percentile
5-year average 2.75 · #25 of 51 in Gold
P/E ratio 8.25 Cheap vs history 19th percentile
5-year average 11.51 · #8 of 32 in Gold
P/S ratio 3.15 In line with history 65th percentile
5-year average 3.05 · forward 2.99 · #12 of 40 in Gold

Vs. peers Gold

Company Market cap P/E (TTM) P/B Div yield
DRDGOLD (DRD) 2.06B 8.05 2.68 2.33%
Newmont (NEM) 119.64B 14.32 3.39 0.90%
Agnico Eagle (AEM) 91.34B 15.44 3.16 0.94%
Barrick Mining (B) 64.49B 10.12 2.36 2.35%
Wheaton Precious Metals (WPM) 60.72B 29.66 6.27 0.54%
Franco-Nevada (FNV) 45.88B 31.10 5.57 0.69%

Other StockVane-tracked companies in the same industry.

Morningstar

★★☆☆☆ Fair value21.28 Economic moatNone UncertaintyHigh

Trading 10.2% above Morningstar's fair value estimate.

Fair value

DRDGold Ltd is assigned a 2-star quantitative star rating, illustrating our stance that this share class is a somewhat unattractive choice, and investors should look elsewhere for more fruitful opportunities. The stock currently trades at a 14% premium over our quantitative fair value estimate of $21.28 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The firm's balance sheet weakens our quantitative valuation. Low leverage can limit a company's ability to invest in growth, potentially reducing shareholder value compared with a balanced use of debt and equity financing. Reflecting the firm's leverage is its debt to EBITDA ratio of 0.003, which ranks in the bottom 10% compared with global peers. With little debt relative to assets, this firm has a "lazy" balance sheet, which can depress returns on invested capital. We believe this is a sign that shares could be overvalued.

Alternatively, the company's favorable dividend structure is reassuring. Dividends represent a stable form of future cash flows returned to shareholders, reducing the perceived risk of a business. The firm's forward dividend yield of 6.0%, for example, falls in the top 10% compared with global peers. Expected dividend payments over the coming year relative to the current share price are favorable, which, despite our unfavorable price/fair value ratio, is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:37:09 · For reference only, not investment advice and not tailored to your situation.